Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society Oct 09, 2014 Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society 12.3 KB ... Read more Summary ToggleTekmira to Present at BIO Investor Forum Oct 02, 2014 Tekmira to Present at BIO Investor Forum 11.9 KB ... Read more Summary ToggleTekmira Achieves $1.5 Million Development Milestone Oct 02, 2014 Tekmira Achieves $1.5 Million Development Milestone 11.9 KB ... Read more Summary ToggleTekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa Sep 23, 2014 Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 21.4 KB ... Read more Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication Aug 20, 2014 Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 18 KB Data From Animal Model Demonstrates Complete Protection Three Days After Infection ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2014 Results Aug 13, 2014 Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 26.9 KB Conference Call at 5:00 pm Eastern Time Today ... Read more Summary ToggleFDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold Aug 07, 2014 FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 12.2 KB Enabling Use of Tekmira's Investigational Therapeutic in Ebola-Infected Patients ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results Aug 07, 2014 Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.2 KB ... Read more Summary ToggleTekmira Provides Update on TKM-Ebola Phase I Clinical Hold Jul 21, 2014 Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 22.2 KB All Other Clinical Development Programs On Track ... Read more Summary ToggleTekmira Receives $1.5 Million Milestone Payment Jul 09, 2014 Tekmira Receives $1.5 Million Milestone Payment 18.3 KB ... Read more Pagination First page First Previous page Previous … Page 29 Current page 30 Page 31 Page 32 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society Oct 09, 2014 Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society 12.3 KB ... Read more Summary ToggleTekmira to Present at BIO Investor Forum Oct 02, 2014 Tekmira to Present at BIO Investor Forum 11.9 KB ... Read more Summary ToggleTekmira Achieves $1.5 Million Development Milestone Oct 02, 2014 Tekmira Achieves $1.5 Million Development Milestone 11.9 KB ... Read more Summary ToggleTekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa Sep 23, 2014 Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 21.4 KB ... Read more Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication Aug 20, 2014 Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 18 KB Data From Animal Model Demonstrates Complete Protection Three Days After Infection ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2014 Results Aug 13, 2014 Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 26.9 KB Conference Call at 5:00 pm Eastern Time Today ... Read more Summary ToggleFDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold Aug 07, 2014 FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 12.2 KB Enabling Use of Tekmira's Investigational Therapeutic in Ebola-Infected Patients ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results Aug 07, 2014 Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.2 KB ... Read more Summary ToggleTekmira Provides Update on TKM-Ebola Phase I Clinical Hold Jul 21, 2014 Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 22.2 KB All Other Clinical Development Programs On Track ... Read more Summary ToggleTekmira Receives $1.5 Million Milestone Payment Jul 09, 2014 Tekmira Receives $1.5 Million Milestone Payment 18.3 KB ... Read more Pagination First page First Previous page Previous … Page 29 Current page 30 Page 31 Page 32 … Next page Next Last page Last
Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society 12.3 KB
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 21.4 KB
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 18 KB
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.2 KB
